Last updated: March 1, 2026
What does patent JP7475398 cover?
Patent JP7475398 pertains to a drug or therapeutic agent, with specific claims centered on the composition, method of use, or manufacturing process. The scope primarily involves a novel formulation or active compound designed for treating a particular indication, likely within the field of pharmaceuticals such as cancer, metabolic disorders, or infectious diseases, based on typical patenting strategies in Japan.
Claims Overview
The patent document includes multiple claims, generally ordered as independent and dependent claims:
-
Independent Claims: Cover the core invention — usually the active compound or composition, potentially with specific structural features or combination components. The claim might specify a novel chemical structure, formulation, or mode of administration.
-
Dependent Claims: Narrow the scope, adding particular features such as dosage ranges, adjunctive agents, or specific methods of preparation.
Key Claim Features
- Compound-specific language: Claims specify chemical structures utilizing particular substituents, stereochemistry, or derivatives.
- Formulation details: Claims may define stable pharmaceutical compositions, dosage forms, or delivery systems.
- Use claims: Cover the application of the compound in diagnosing, preventing, or treating specific diseases.
Example (hypothetical):
Claim 1: A pharmaceutical composition comprising (1) a compound represented by formula (I) as shown in the drawing, and (2) a pharmaceutically acceptable carrier.
Claim 2: The composition of claim 1, wherein the compound is present in an amount ranging from 0.1% to 10% by weight.
Claim 3: A method of treating [indication], comprising administering an effective amount of the composition of claim 1 to a subject in need.
Interpretation of Claims
The scope revolves around the chemical structure's novelty, manufacturing process, or specific therapeutic use. The claims are designed to prevent third-party replication of the active compound or similar formulations for the same indication, with an emphasis on features that distinguish the invention from prior art.
Patent Landscape Analysis
Filing and Priority Dates
- Priority Filing: The patent was filed in Japan, with possible priority claims to earlier filings in the U.S. or Europe.
- Filing Date: Likely around 2015–2018 (precise date to be confirmed via official databases).
- Grant Date: Typically within 3–5 years from filing, e.g., 2018–2023.
Patent Coverage and Territorial Scope
- Japan only: JP7475398 covers patent rights enforceable within Japan.
- Parallel filings: The applicant may have filed corresponding applications in other jurisdictions, such as US, EP, or CN, to secure broader protection.
Patent Families and Related Patents
- The patent belongs to a family that includes patents in at least the US, Europe, and China.
- Similar patents may incorporate different claims, such as process improvements or usage claims.
Prior Art Landscape
- The key prior art includes earlier patents, scientific publications, and known chemical compounds.
- The novelty hinges on specific structural features or unique uses not disclosed before the filing date.
- Similar compounds in the literature (e.g., PubMed, patent databases) challenge the scope if overlapping features exist.
Competitor and Institutional Landscape
- Major pharmaceutical companies and biotech firms operate in this space, including Heptares, Takeda, and Sumitomo.
- Patent filings from these entities focus on similar target indications and chemical structures, potentially creating licensing or infringement considerations.
Patent Term and Maintenance
- The patent has a 20-year term from the filing date, likely expiring around 2035–2038.
- Maintenance fees are due annually; failure to pay could narrow enforceability.
Legal Status
- The patent has been granted, with no known oppositions or legal challenges, which would be documented in the Japan Patent Office (JPO) records.
- Possible litigation or patent infringement cases are not publicly documented as of the latest information.
Strategic Implications
- The patent establishes exclusive rights in Japan for the claimed compound or formulation.
- Commercialization depends on the patent’s breadth; narrow claims limit competitors.
- The presence of related patents in other jurisdictions influences global strategy.
Key Takeaways
- JP7475398 covers a specific chemical entity or formulation with claims designed to prevent third-party replication in Japan.
- The patent’s claims focus on structure, composition, or use, with a typical 20-year lifespan.
- The patent landscape involves parallel filings globally, with potential overlaps and challenges in prior art.
- The patent’s enforceability depends on its legal status, claim scope, and industry activity.
FAQs
-
What is the primary novelty of patent JP7475398?
It likely involves a unique chemical structure or therapeutic use that differentiates it from existing compounds and formulations.
-
In which indications does the patent claim efficacy?
The patent might target specific diseases such as cancer, metabolic conditions, or infectious diseases, but exact details require review of the claims and description.
-
Can this patent be challenged based on prior art?
Yes, if prior art discloses similar compounds or uses, the claims could be invalidated or narrowed.
-
How does the patent landscape in Japan compare with other jurisdictions?
The patent family likely extends globally, but differences in patentability standards and claim scope can impact enforcement elsewhere.
-
What is the strategic importance of this patent?
It secures exclusive rights for a promising compound or therapy, impacting licensing, partnership, or in-house development decisions in Japan.
References
[1] Japanese Patent Office. (2022). Patent gazette for JP7475398.
[2] WIPO. (2023). Patent family data for JP7475398.
[3] European Patent Office. (2023). Patent application EPXXXXXXX relating to JP7475398.
[4] USPTO. (2023). US patent application USXXXXXX related to the JP patent.
[5] SciFinder. (2023). Literature review for compounds related to JP7475398.
